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Summary 43	
Objective: Research findings on the relationship between serum androgens and adipose tissue 44	
in older females are inconsistent. We aimed to clarify the relationship using state-of-the art 45	
techniques to evaluate associations between body fat distribution and plasma testosterone (T) 46	
levels in older postmenopausal women.  47	
Design: Observational, cross-sectional study of healthy, community dwelling postmenopausal 48	
women 49	
Patients and Measurements: Postmenopausal women, (60-80 years old) were included in this 50	
study. Overall body composition was evaluated by dual-energy x-ray absorptiometry. 51	
Abdominal and thigh fat depots were measured by magnetic resonance imaging. Circulating T 52	
concentrations by liquid chromatography-tandem mass spectrometry. 53	
Results: Thirty-five women (66.6 ± 0.8 years) participated in this study. T levels were positively 54	
associated with clinical proxy measure of adiposity including weight (r=0.39), BMI (r=0.43) 55	
and waist circumference (r=0.39) (all p<0.05). Fat mass and percent body fat were correlated 56	
with T levels (r=0.42 and 0.38 respectively, both p<0.05). T correlated with overall and 57	
superficial abdominal fat (r=0.34 and 0.37 respectively, both p<0.05) but not with visceral 58	
adipose tissue. T increased with greater thigh fat (r=0.49, p<0.05) in both superficial and deep 59	
depots (r=0.50 and 0.35 respectively, both p<0.05).  60	
Conclusion: Our results suggest that postmenopausal women with higher circulating T levels 61	
have both higher regional and overall body adiposity. These findings underscore the sexual 62	
dimorphism in the relationship between serum androgen levels and adiposity.  63	
 64	
Key words: body composition, regional adiposity, sexual dimorphism, superficial adipose 65	
tissue, visceral adipose tissue, IMAT 66	
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Introduction  68	
Testosterone is produced by the gonads and to a lesser extend the adrenal glands. Testosterone 69	
(T) has important physiologic effects in both sexes. It promotes the formation of lean muscle 70	
mass 1, reduces percent body fat 1,2, affects energy levels 3, contributes to the development and 71	
maintenance of bone density 4 and has significant effects on libido, sexual function, mood and 72	
general well-being 5. As the dominant sex steroid, circulating T concentrations are 73	
approximately 10 to 20-fold higher in men compared to women 6,7. Circulating sex steroid 74	
levels decrease with aging 8-10. After menopause, T levels in women fall to even lower levels 75	
due to diminished ovarian function 11. In contrast, aging is associated with increased adiposity.  76	
 77	
Adipose tissue has a central role in triglyceride storage 12 and is an endocrine organ. In addition 78	
of regulating the synthesis and release of adipokines 13,14, data suggest that adipose tissue 79	
represents an intracrine source of androgens synthesis 15 and recent mechanistic studies have 80	
begun to uncover site-specific intra-adipose mechanisms of androgen activation 16-18. Adipose 81	
tissue distribution has long been acknowledged as sexually dimorphic 19,20. Men typically 82	
accumulate fat in the abdominal region (i.e. “apple-shaped”, android pattern) whereas women 83	
tend to accumulate fat in the gluteal-femoral region (i.e. “pear-shaped”, gynoid pattern) 21,22. 84	
Following menopause, visceral fat deposition increases with a parallel increase in metabolic 85	
risk 19. The linkage between adiposity and metabolism has been well established 23,24 as is the 86	
sexually dimorphic relationship between sex steroids and insulin sensitivity 25. For example, 87	
men with higher T levels have more lean muscle mass and are more insulin sensitive 26 while 88	
women with high androgen levels (e.g. polycystic ovarian syndrome, PCOS) exhibit increased 89	
insulin resistance 27,28. Whereas an inverse relationship has been well established between T 90	
and adiposity in males 6,29,30, the exact relationship in women is unclear. Studies are conflicting. 91	
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Some report positive associations 31,32 while others have found either negative 33 or no 92	
association at all 6,34,35.  93	
 94	
These inconsistent findings may result from methodological limitations in measuring T at low 95	
levels. Women have very low circulating T levels and traditional assays, such as 96	
radioimunnoassays (RIA), are less reliable near the level of detection 36. However, advances in 97	
sex steroid measurement and imaging technologies now make it possible to investigate this 98	
methodologically challenging question with precision. The sensitivity and accuracy of liquid 99	
chromatography-tandem mass spectrometry (LC-MS/MS) make it the “gold standard” for 100	
measuring circulating sex steroids 37,38. Similarly, quantifying body fat depots has been 101	
imprecise and approaches have been proxy in nature (i.e. BMI, waist circumference, skin-fold 102	
measurement). Dual energy absorptiometry (DXA) and magnetic resonance imaging (MRI) 103	
techniques provide precise measures of whole body and regional adiposity. Therefore, the aim 104	
of this study was to evaluate levels of circulating T in aging post-menopausal women using 105	
state of the art tools and to investigate its relationship with whole-body and regional adiposity.  106	
 107	
Materials and Methods 108	
Study design, participants and clinical assessment: 109	
	110	
Community dwelling, stable-weight women aged 60-80 years were recruited for the study. 111	
Postmenopausal women (defined as no menstrual periods for more than one year), in good 112	
general health, not taking hormonal replacement therapy (or herbal formulations) to treat 113	
menopausal symptoms at least 6 months prior to enrollment were included. Those women who 114	
reported tobacco use (e.g. active smokers), steroid medications, prior diagnosis of diabetes or 115	
abnormal thyroid, liver or kidney function tests were excluded. The ethics committee of the 116	
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Canton (state) Vaud approved the study and all participants provided written informed consent 117	
prior to the initiation of study procedures. 118	
 119	
Anthropometric and body composition assessment 120	
Participant height (cm) was measured using a wall-mounted stadiometer and body weight (kg) 121	
using a standard calibrated medical scale (Seca GmBh, Hamburg, Germany) in the fasting state 122	
and wearing a hospital gown. Body mass index was calculated as weight divided by height 123	
squared (Kg/m2). Lean and fat masses were determined by dual energy X-ray absorptiometry 124	
(DXA) (Discovery A; Hologic Inc., Bedford, MA) under controlled conditions (i.e. proper 125	
hydration and not exercising prior to the test). The DXA scanner was calibrated prior to 126	
imaging. Each scan was performed by a trained technician and a study investigator supervised 127	
the proper position and placement of markers.  128	
 129	
Regional adipose tissue measurements 130	
Abdominal and thigh images were obtained using a 3-tesla magnet (VERIO; SIEMENS, 131	
Erlangen, Germany). Thirteen series of five images with 10 mm thickness and 10 mm gap 132	
between images were taken for each subject in the supine position from the sternal notch to the 133	
patella. One subject did not complete the imaging series due to claustrophobia. All images were 134	
de-identified and analyzed in a blinded fashion.  135	
	136	
Images used for the abdominal region spanned the femur heads (first image) to the heart (last 137	
image). Abdominal fat volumes were determined using a point counting program (MATLAB 138	
R2007a, MathWorks, Natick, MA, USA) as previously described 39. Briefly, after contour lines 139	
are drawn to separate visceral from subcutaneous tissues and a standardized grid of 15 mm is 140	
superimposed on the image series. Grid crossings falling on adipose tissue are counted 141	
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providing an unbiased and accurate estimation of volume 40. The intra- and inter-rater 142	
coefficients of variations (CV) were 2.2 % and 4.3 % respectively for visceral adipose tissue 143	
(VAT) and 2.7 % and 1.1 % respectively for abdominal subcutaneous adipose tissue (ASAT).  144	
 145	
Thigh adipose tissue volumes were analyzed with the MIPAV software (Medical Image 146	
Processing, Analysis, and Visualization, 7.2.0 version, NIH, Bethesda, USA). First the length 147	
of the femur was estimated using all images spanning the greater trochanter to the patella. The 148	
middle 5 images were selected with the central image corresponding to the center of the femur. 149	
Muscle, subcutaneous and intermuscular adipose tissue (IMAT) were measured in each image 150	
as described elsewhere 41. In brief, images were first homogenized using an established 151	
normalization (N3) algorithm to correct for varying shading caused by radiofrequency coil 152	
uniformity or gradient driven eddy currents 42. Pixels of bone, bone marrow and bone fat were 153	
masked and excluded from fat analysis. Two concentric lines were drawn. The first line defined 154	
the limit of the leg (including skin). The second line marked the fascia surrounding muscles 155	
(excluding subfascial adipose tissue). The adipose tissue between the two lines was defined as 156	
thigh subcutaneous adipose tissue (TSAT). To separate fat from muscle within the fascia, five 157	
or more volumes of interest were placed over the cleanest muscular areas (without fat), in fat 158	
and between both tissues. A histogram of pixel intensities within the volumes of interest 159	
allowed defining each image specific threshold fat/muscle. IMAT was identified as all pixels 160	
above this threshold. TSAT and IMAT in each image are expressed in cm2. To obtain volume, 161	
each area of interest was summed across the 5 images. To account for gaps between images, 162	
each image is duplicated. Units were transformed from cm3 to liters. Intra- and inter-rater CV 163	
were 5.9 % and 6.3 % respectively for TSAT and 6.9 % and 9.0 % respectively for IMAT.	  164	
 165	
Biochemical analysis 166	
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 Blood samples were collected following a 12-hour overnight fast, spun and plasma aliquots 167	
were frozen at -80C prior to measurement. Blood glucose, total cholesterol, triglycerides and 168	
HDL cholesterol were analyzed at the hospital laboratory of analytical biochemistries using a 169	
Cobas automated analyzer (Cobas 8000, Roche-Diagnostics, Basel, Switzerland). 	Glycated 170	
hemoglobin was measured using high performance liquid chromatography (HPLC D-100, Bio-171	
Rad Laboratories, CA, USA). The limit of detection for glucose, triglycerides, total and HDL 172	
cholesterol are 0.11, 0.1, 0.1 and 0.08 (mmol/L) respectively and 3.5% for HbA1c. For all these 173	
analytes, the intra- and interassay coefficients of variation are <3%.  174	
 175	
Liquid chromatography high-resolution tandem mass spectrometry  176	
Details on sample preparation, calibrators and control materials have been described in details 177	
previously 36. Briefly, frozen plasma samples were thawed at room temperature, vortex mixed, 178	
centrifuged (20,000x g, 4oC, 5 min) and pipetted (100µl) into a 96 deep-well plate (Eppendorf, 179	
Hamburg, Germany). Calibrators, controls and internal standards were included in the well 180	
plate (100µl each). After top sealing, the plates were placed onto an Orbit P2 sample shaker 181	
(Labnet, Edison, NJ, USA) for 10 minutes followed by centrifugation (2,500 x g, 4oC, 1 min). 182	
A solid phase extraction 96 well plate (Oasis MCX, Walters, MA, U.S.A) was prepared by 183	
passing 200µl methanol followed by 200µl of ultra-pure water through each well using a 184	
positive pressure processer (Walters, MA, U.S.A). The samples and the calibrators were added 185	
to individual wells along with internal standard mix to a total volume of 200µl per well. 186	
Following washing steps with 5%NH4OH and 20% MeOH, final contents were evaporated 187	
under N2 using a Turbo Vap 96 system (Biotage, Uppsala, Sweden). Each well content was 188	
reconstituted with 75µl (MeOH: H2O / 2:3) prior to LC-HRMS/MS analysis. The LC-189	
HRMS/MS	36 system uses an auto sampler (CTC-PAL Analytics, Zwingen, Switzerland), an 190	
ultra-high pressure pump unit and an Orbitrap Q-Exactive mass spectrometer system (Thermo 191	
Scientific, Waltham, MA, USA). Xcalibur software version 2.2 (Thermo Fisher Scientific, 192	
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Waltham, MA, USA) was used for data acquisition, processing and reporting. The level of 193	
detection for T is 0.01 nmol/L 43 and inter-serial CV was <5%.  194	
 195	
Statistical Procedures 196	
Statistical analysis was performed using JMP v12 for windows (SAS, Cary, NC, USA). Values 197	
are expressed as mean ± standard error of the mean and as 95% confidence interval. 198	
Associations were assessed using the Spearman rank correlation coefficient. A p value < 0.05 199	
was considered statistically significant. 200	
 201	
Results 202	
Thirty-five postmenopausal women participated in the study (66.6±0.8, range 61-76 years). 203	
BMI and waist circumference (WC) were on average 25.5 ± 1.0 Kg/m2 and 86.9 ± 2.8 cm 204	
respectively. Fasting total cholesterol (5.62 ± 0.13 mmol/L), HDL cholesterol (1.89 ± 0.07 205	
mmol/L), triglycerides (1.13 ± 0.11 mmol/L), glucose (5.53 ± 0.08 mmol/L), HbA1c (5.57 ± 206	
0.04 %) and T (0.66 ± 0.06 nmol/L) were within age-appropriate normal ranges.  207	
 208	
Whole body composition and regional adipose tissue depositions are presented in Table 1. We 209	
were unable to acquire leg and abdominal MRI in one subject due to a previously unrecognized 210	
claustrophobia - all other data were obtained and included in the analysis. Abdominal and thigh 211	
regions had similar proportions of superficial to deep fat. In the abdomen, 2/3 of adipose tissue 212	
was ASAT and 1/3 VAT. In the thigh, 2/3 of fat was TSAT and 1/3 IMAT.  213	
 214	
T was positively associated with clinical proxy measures of adiposity such as weight (ρ=0.39, 215	
p=0.02), BMI (ρ=0.43, p=0.01) and WC (ρ=0.39, p=0.03). Relationships between T and 216	
adiposity parameters obtained by DXA (fat mass, % body fat) and those obtained from MRI 217	
	 9	
(abdominal and thigh depots) are shown in Figure 1. No significant associations were found 218	
between T and either lean mass, glucose, HbA1c, cholesterol or triglycerides.  219	
 220	
The achieved power was computed using the absolute rho as the effect size. For an alpha level 221	
of 0.05, a sample size of 34 and a |ρ| of 0.4 (average of all correlation coefficients between T 222	
and all measures of adiposity 0.397), the calculated post-hoc power was of 0.80. 223	
 224	
Discussion 225	
In men, there is a clear inverse association between T levels and adiposity 6,44,45 yet available 226	
evidence on the relationship between circulating androgens and fat depots in women is limited 227	
and conflicting 31-34,46,47. Using state of the art measurement techniques in postmenopausal 228	
women, we identified positive associations between plasma T and several measures of 229	
adiposity, (i.e. fat mass, percent of body fat, abdominal and thigh fat depots) as well as with 230	
clinical surrogates such as waist circumference, weight and BMI.  231	
 232	
It is well established that adiposity is associated with numerous metabolic disorders 48. Notably, 233	
both the quantity and distribution of body fat is sexually dimorphic 21,22. There are however, 234	
large metabolic differences between adipose tissue depots 23. In both sexes, increased VAT is 235	
associated with metabolic risk including hyperinsulinemia, dyslipidemia and hypertension 48,49. 236	
In older women, TSAT is associated with protective health benefits including greater insulin 237	
sensitivity 24 independent of abdominal fat 50. Recently, the difference between TSAT and 238	
IMAT has received increasing attention as these depots are thought to have opposite 239	
relationships with insulin sensitivity 51-53. Given the important differences in regional 240	
depositions and metabolism, we sought to explore the relationship between T and specific thigh 241	
and abdominal fat deposition by employing state of the art measurements of regional adipose 242	
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tissue. Using volumetric MRI measures	41, we found thigh adipose tissue, deep and superficial, 243	
to be positively associated with circulating T levels in postmenopausal women. Previously, De 244	
Pergola et al.	found an inverse relationship with femoral superficial adipose tissue measured by 245	
ultrasound 33. Moreover, a recent study using a single mid-thigh computed tomography (CT) 246	
image observed a positive relationship between T and overall thigh adipose tissue 46. To our 247	
knowledge, the relationship of IMAT and TSAT with T observed in our cohort has yet to be 248	
described in either men or women.   249	
 250	
Anthropometric measures such as BMI, WC and waist to hip ratio (WHR) are commonly used 251	
in clinical and epidemiological settings as proxy measures of adiposity to predict metabolic 252	
morbidity 3,19. We identified positive associations between T and WC, weight and BMI 253	
respectively. This is in agreement with large epidemiological studies in the same populations 254	
of interest that have examined WC, or WHR, and T measured by RIA 31,54. In contrast to proxy 255	
methods, DXA and underwater weighing measure whole body adiposity, yet these techniques 256	
require specialized equipment. Using DXA, we observed positive relationships between T, total 257	
fat mass and percent body fat. Our results are in agreement with some studies that used DXA 258	
to measure adiposity in women 7,32,47, but not with others. Indeed, several studies have failed to 259	
show any relationship between T levels and body fatness assessed by either DXA 34, underwater 260	
weighing 46 or bioimpedence 35.  261	
 262	
Our volumetric measures of total abdominal adiposity were positively related to T. This was 263	
also true for ASAT but not VAT. Our results are in contrast to studies measuring abdominal 264	
adiposity in men	 6. In women, data are conflicting, particularly in postmenopausal females. 265	
Indeed, in younger women, greater abdominal fat is associated with higher circulating 266	
androgens 55. In healthy middle-aged Australian white women, baseline T predicted the 267	
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accumulation of VAT five years later 56. In a clinical trial, Lovejoy et al. 57 demonstrated 268	
administering a weak androgen (nandrolone decanoate) induced elevated VAT levels in obese 269	
white women.	Among postmenopausal women, a negative association was found between T 270	
and VAT assessed by either ultrasound 33 or via single CT image 58. Further, two recent studies 271	
using a single CT image to assess VAT did not find any associations between abdominal 272	
adipose tissue and T 6,46.  273	
 274	
The inconsistent findings may result from methodological limitations in measuring T at very 275	
low levels. Both RIA and immunoassays suffer inadequate sensitivity and lack precision for 276	
measuring androgens in women at very low levels 59. Such methods are problematic for studies 277	
of female population and particularly postmenopausal women. A relative strength of this study 278	
was that we employed LC-HRMS/MS 37,38. This method is particularly appropriate for 279	
measuring T in postmenopausal women as T levels can be detected as low as 0.01nM 43. It is 280	
worthwhile to note that in this population, several confounding variables can affect serum T 281	
levels (e.g. oophorectomy, hormone replacement therapy). While our sample size can be 282	
interpreted as relatively small, none of the participants had such confounding factors. Another 283	
strength of this study is that we used multiple measures of adiposity with different levels of 284	
granularity, ranging from anthropometric markers to overall body fatness and regional fat 285	
depots (superficial and deep). Importantly, when quantifying abdominal adipose tissue, we used 286	
whole abdomen volume which is more reproducible than partial abdomen measures	 60 or a 287	
single CT image.  288	
 289	
Among our limitations, we were unable to measure free T (e.g. by equilibrium dialysis) or 290	
compute indirectly free T levels through measures of sex-hormone binding globulin. Although 291	
we recognize that free T levels would be of interest regarding the biological effects of 292	
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testosterone, we believe that the study objective was realized without free T measurement or 293	
calculation given the accuracy and appropriateness of the employed LC-HRMS/MS 294	
methodology in the population of interest.  Our data only provide observations of associations 295	
in older postmenopausal women thus findings should not be generalized to younger 296	
populations. In addition, the sample was entirely white European (Caucasian) and it is possible 297	
that racial differences exist. Lastly, given that adipose tissue biopsies were not performed in 298	
this study, we do not provide mechanistic insights. Indeed, mechanistic studies of androgen 299	
conversion within adipose tissue show evidence that specific enzymes capable of activating 300	
androstenedione to testosterone are higher in adipocytes from ASAT than VAT	 15-17, while 301	
other androgen inactivating enzymes are detected in adipocytes from VAT but not ASAT	18,61. 302	
Further research is needed to elucidate the mechanism of the observed associations, particularly 303	
those regarding regional superficial and deep adipose depots, and examine the clinical impact 304	
on heath in postmenopausal women. 305	
 306	
Conclusion 307	
In summary, among a cohort of healthy postmenopausal women, plasma T levels were 308	
positively associated with superficial and deep fat depositions in the thigh, superficial 309	
abdominal adipose tissue as well as with overall body adiposity. Our findings emphasize the 310	
clear gender differences with opposing relationships between androgens and adiposity. 311	
	312	
	313	
	314	
	315	
	316	
 317	
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Figure legend 320	
 321	
Figure 1: Associations between testosterone and measures of adiposity in post-322	
menopausal women 323	
AT is adipose tissue, ASAT is abdominal subcutaneous AT, TSAT is thigh subcutaneous AT, 324	
VAT is visceral AT, IMAT is intermuscular AT. Solid lines are the tendency lines, dotted 325	
lines represent the 95% CI. N=35 for fat mass and body fat. N=34 for abdominal AT, thigh 326	
AT, ASAT, TSAT, VAT and IMAT.   327	
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Tables 
 
Table 1: Whole body composition and regional adipose tissue deposition 
VARIABLES Mean ± SEM 95% CI Range (min – max) 
DXA (n=35) 
Fat mass (Kg)                          
Lean mass (Kg) 
Body fat (%) 
Abdominal MRI (n=34)                                   
Abdominal AT (L) 
VAT (L) 
ASAT (L) 
Thigh MRI (n=34) 
Thigh AT (L) 
TSAT (L) 
IMAT (L) 
 
24.36 ± 1.92 
42.84 ± 1.07 
33.53 ± 1.46 
12.60 ± 1.20 
3.57 ± 0.30 
9.03 ± 0.95 
 
1.26 ± 0.09 
0.98 ± 0.07 
0.27 ± 0.02 
 
(20.45 - 28.26) 
(40.68 - 45.01) 
(30.56 - 36.50) 
 
(10.17 - 15.04) 
(2.95 - 4.19) 
(7.10 - 10.95) 
 
(1.08 - 1.44) 
(0.85 - 1.12) 
(0.23 - 0.30) 
 
(7.56 - 46.34) 
(32.04 - 56.03) 
(17.40 - 46.90) 
 
(2.44 – 27.47) 
(0.76 – 8.12) 
(1.68 – 22.14) 
 
(0.50 – 2.41) 
(0.39 – 1.69) 
(0.10 – 0.54) 
Kg= kilograms, L = liters, AT= adipose tissue, VAT=visceral AT, ASAT=abdominal subcutaneous AT, 
TSAT=thigh subcutaneous AT, IMAT=intermuscular AT 	
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